Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: ADHD, Opioid-Related Disorders, Cocaine Dependence

In brief

The purpose of this study is to treat Adult Attention Deficit Hyperactivity Disorder (ADHD) in methadone patients.

Key facts

Study ID

NCT00061087

Run by

New York State Psychiatric Institute

People needed

115

Starts

1998-02-01

Expected to finish

2004-10-01

Last updated by the study team

2019-04-23

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals who meet DSM-IV criteria for opiate dependence and are currently maintained on methadone
• Patients must meet DSM-IV criteria for persistent adult ADHD
• Must be on stable methadone dose for at least 3 weeks
• Individuals positive for HIV will not be excluded.

You may not qualify if…

• Patients meeting DSM-IV criteria for current psychiatric disorders (other than ADHD or substance abuse) which requires psychiatric intervention
• Patients who are physiologically dependent on either sedatives or alcohol such that they experience symptoms requiring medical attention during periods of abstinence or significant reduction in amount of use
• Individuals diagnosed with other forms of adult ADHD other than persistent, particularly substance-induced ADHD
• Those who have an unstable medical condition which might make participation hazardous, including but not restricted to: uncontrolled hypertension, (SBP >160, DBP>100, PULSE >110), uncontrolled liver disease, uncontrolled diabetes, acute hepatitis, uncontrolled heart disease as indicated by history or abnormal ECG, glaucoma, or history of urinary retention or seizures, or advanced AIDS will not be included
• Patients who are taking prescription psychotropic medications other than methadone
• Patients who have exhibited suicidal or homicidal behavior within the past two years
• Patients with known sensitivity to MPH or BPR
• Patients with cognitive impairment or who cannot read or understand the self-report assessment forms unaided or are so severely disabled they cannot comply with the requirements of the study.
• Patients unable to give full and informed consent
• Patients with a history of an eating disorder
• Patients recently convicted of a violent crime. (last two years)
• Nursing mothers and pregnant women

Where it is running

• Research Foundation for Mental Hygiene, Inc. — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.